Frequencies of CYP and GST gene polymorphisms in CML cases and controls
Allele . | CML cases, no. (%)* . | Controls, no. (%)* . | OR† (95% CI‡) . | P . |
---|---|---|---|---|
CYP1A1∗2Apresent | 9/141 (6.4) | 24/150 (16.0) | 0.36 (0.16-0.80) | .0097 |
CYP1A1∗2B present | 9/141 (6.4) | 13/150 (8.7) | 0.72 (0.30-1.74) | .46 |
CYP1A1∗4present | 19/141 (13.5) | 16/150 (10.7) | 1.30 (0.64-2.65) | .46 |
GSTM1null | 77/141 (54.6) | 84/148 (56.8) | 0.92 (0.58-1.46) | .71 |
GSTT1 null | 31/141 (22.0) | 26/150 (17.3) | 1.34 (0.75-2.40) | .32 |
Allele . | CML cases, no. (%)* . | Controls, no. (%)* . | OR† (95% CI‡) . | P . |
---|---|---|---|---|
CYP1A1∗2Apresent | 9/141 (6.4) | 24/150 (16.0) | 0.36 (0.16-0.80) | .0097 |
CYP1A1∗2B present | 9/141 (6.4) | 13/150 (8.7) | 0.72 (0.30-1.74) | .46 |
CYP1A1∗4present | 19/141 (13.5) | 16/150 (10.7) | 1.30 (0.64-2.65) | .46 |
GSTM1null | 77/141 (54.6) | 84/148 (56.8) | 0.92 (0.58-1.46) | .71 |
GSTT1 null | 31/141 (22.0) | 26/150 (17.3) | 1.34 (0.75-2.40) | .32 |